1-sulfonylindole derivatives, their preparation and their use as 5-HT6 ligands
    23.
    发明授权
    1-sulfonylindole derivatives, their preparation and their use as 5-HT6 ligands 失效
    1-磺酰基吲哚衍生物,它们的制备及其作为5-HT6配体的用途

    公开(公告)号:US07655690B2

    公开(公告)日:2010-02-02

    申请号:US10566400

    申请日:2004-07-29

    CPC classification number: C07D401/04 C07D209/40 C07D471/04

    Abstract: The present invention refers to new sulfonamide derivatives, of general formula (Ia, Ib, Ic), (I), (Ia, Ib, Ic), optionally in form of one of their stereoisomers, preferably enantiomers or diastereomers, their racemate, or in form of a mixture of at least two of their stereoisomers, preferably enantiomers or diastereomers, in any mixing ratio, or their salts, preferably their corresponding physiologically acceptable salts or corresponding solvates; to the processes for their preparation, to their application as medicaments in human and/or veterinary therapeutics, and to the pharmaceutical compositions containing them. The new compounds of the present invention can be used in the pharmaceutical industry as intermediates and for preparing medicaments.

    Abstract translation: 本发明涉及通式(Ia,Ib,Ic),(I),(Ia,Ib,Ic)的新型磺酰胺衍生物,其任选为其立体异构体之一的形式,优选对映异构体或非对映异构体,其外消旋体或 其形式为至少两种其立体异构体,优选对映异构体或非对映异构体,以任何混合比例的混合物,或其盐,优选其相应的生理学上可接受的盐或相应的溶剂合物; 其制备方法,作为人和/或兽医治疗剂中的药物的应用,以及含有它们的药物组合物。 本发明的新化合物可用于制药工业中作为中间体并用于制备药物。

    Derivatives of pyrazoline, procedure for obtaining them and use thereof as therapeutic agents
    24.
    发明授权
    Derivatives of pyrazoline, procedure for obtaining them and use thereof as therapeutic agents 失效
    吡唑啉的衍生物,其获得方法和用途作为治疗剂

    公开(公告)号:US07504519B2

    公开(公告)日:2009-03-17

    申请号:US11571989

    申请日:2004-09-22

    CPC classification number: C07D231/06

    Abstract: The invention relates to derivatives of general formula (I), and to their pharmaceutically acceptable salts, their stereoisomeric forms, preferably their pure enantiomeric or diastereomeric forms and their racemic forms, or a mixture thereof in any mixture ratio, and their N-oxides and the corresponding solvates or hydrates, to the processes for obtaining said derivatives and to the pharmaceutical compositions which contain them.Said derivatives are useful as anti-inflammatory and analgesic agents. in which R and R1 are different from each other and are selected from H and

    Abstract translation: 本发明涉及通式(I)的衍生物及其药学上可接受的盐,它们的立体异构形式,优选它们的纯对映异构体或非对映体形式及其外消旋形式或其任何混合比例的混合物,以及它们的N-氧化物和 相应的溶剂合物或水合物,获得所述衍生物的方法和含有它们的药物组合物。 所述衍生物可用作抗炎和止痛剂。 其中R和R 1彼此不同并且选自H和

    Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators
    27.
    发明申请
    Indol-4 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators 失效
    Indol-4磺酰胺衍生物,它们的制备及其用途5-ht-6作为调节剂

    公开(公告)号:US20070185158A1

    公开(公告)日:2007-08-09

    申请号:US10566164

    申请日:2004-07-29

    CPC classification number: C07D409/12 C07D209/08 C07D513/04

    Abstract: The present invention refers to new sulfonamide derivatives, of general formula (1a, 1b, 1c), optionally in form of one of their stereoisomers, preferably enantiomers or diastereomers, their racemate, or in form of a mixture of at least two of their stereoisomers, preferably enantiomers or diastereomers, in any mixing ratio, or their salt thereof s, preferably the corresponding, physiologically acceptable salt thereofs, or corresponding solvate thereofs; to the processes for their preparation, to their application as medicaments in human and/or veterinary therapeutics, and to the pharmaceutical compositions containing them.

    Abstract translation: 本发明涉及通式(1a,1b,1c)的新的磺酰胺衍生物,任选地以其立体异构体之一的形式,优选对映体或非对映异构体,其外消旋体或其至少两种立体异构体的混合物的形式 ,优选对映异构体或非对映体,以任何混合比例,或其盐,优选相应的生理学上可接受的盐或其相应的溶剂合物; 其制备方法,作为人和/或兽医治疗剂中的药物的应用,以及含有它们的药物组合物。

Patent Agency Ranking